94.99 - 101.71
82.92 - 275.94
Join Discuss about HSKA with like-minded investors
Next Dividend Date
Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
CEO: Kevin Wilson
HQ: 3760 Rocky Mountain Ave Loveland, 80538-7084 Colorado